Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

<div>Schematic showing that meloxicam inhibits HCC and increases the efficacy of <i>α</i>PD-1 in the treatment of HCC.</div>

Journal of Oncology

Figure 8: Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway 